Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.53−0.03 (-5.79%)
Close on Nov 18, 2026Market cap $1.36MP/E –Yield –
Calidi Biotherapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Calidi Biotherapeutics's revenue for the twelve months ending Dec 31, 2022 was $45.00K. For fiscal 2022 it was $45.00K.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $45.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
See a number that looks wrong?